Insider trading

Period: 12 months Stock: QURE Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

37 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

37 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

37 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

37 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
37 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
37 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

37 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Jul 2026
Kapusta Matthew C CEO, Managing Director
Sold on a plan 3×
$952.05K 21,082 at 45.16
3.9%
Planned (10b5-1)
30 Jun 2026
Abi-Saab Walid Chief Medical Officer
Sold on a plan 2×
$1.39M 30,000 at 46.42
16.8%
Planned (10b5-1)
30 Jun 2026
Kaye Jack Director
Sold on a plan 2×
$983.03K 21,167 at 46.44
44.9%
Planned (10b5-1)
26 Jun 2026
Abi-Saab Walid Chief Medical Officer
Sold at will
$67.20K 1,434 at 46.86
0.8%
Not planned
25 Jun 2026
Kapusta Matthew C CEO, Managing Director
Sold on a plan
$1.44M 28,716 at 50.02
5.2%
Planned (10b5-1)
24 Jun 2026
Kapusta Matthew C CEO, Managing Director
Sold on a plan
$334.80K 6,696 at 50.00
1.3%
Planned (10b5-1)
18 Jun 2026
Kapusta Matthew C CEO, Managing Director
Sold on a plan 2×
$2.08M 41,671 at 50.00
7.4%
Planned (10b5-1)
17 Jun 2026
Kapusta Matthew C CEO, Managing Director
Sold on a plan 6×
$7.29M 164,429 at 44.32
22.7%
Planned (10b5-1)
17 Jun 2026
Sold on a plan 3×
$526.48K 11,685 at 45.06
21.3%
Planned (10b5-1)
17 Jun 2026
Kaye Jack Director
Sold on a plan
$225.41K 5,295 at 42.57
16.9%
Planned (10b5-1)
15 Jun 2026
Sold on a plan
$278.50K 10,000 at 27.85
18.8%
Planned (10b5-1)
15 Jun 2026
Potts Jeannette Chief Legal Officer
Sold at will
$144.91K 5,237 at 27.67
3.8%
Not planned
11 Jun 2026
O'Keefe Kylie Chief Customer & Strat Officer
Sold at will
$431.23K 15,936 at 27.06
12.8%
Not planned
11 Jun 2026
Gut Robert Director
Sold on a plan
$73.77K 2,726 at 27.06
7.8%
Planned (10b5-1)
11 Jun 2026
Meek David D. Director
Sold at will
$53.93K 1,993 at 27.06
4.8%
Not planned
11 Jun 2026
Sold at will
$53.93K 1,993 at 27.06
4.4%
Not planned
11 Jun 2026
POST LEONARD E Director
Sold at will
$53.93K 1,993 at 27.06
5.3%
Not planned
11 Jun 2026
Kaye Jack Director
Sold at will
$53.93K 1,993 at 27.06
7.1%
Not planned
11 Jun 2026
Sold at will
$53.93K 1,993 at 27.06
5.6%
Not planned
11 Jun 2026
Sold at will
$53.93K 1,993 at 27.06
4.4%
Not planned
10 Jun 2026
Gut Robert Director
Sold on a plan 3×
$196.72K 7,552 at 26.05
21.6%
Planned (10b5-1)
3 Jun 2026
Kaye Jack Director
Sold on a plan
$79.38K 2,645 at 30.01
11.5%
Planned (10b5-1)
8 May 2026
Abi-Saab Walid Chief Medical Officer
Sold on a plan 2×
$1.13M 45,000 at 25.06
21.0%
Planned (10b5-1)
4 Mar 2026
Kapusta Matthew C CEO, Managing Director
Sold at will
$132.10K 14,581 at 9.06
2.2%
Not planned
4 Mar 2026
KLEMT CHRISTIAN Chief Financial Officer
Sold at will
$108.72K 12,000 at 9.06
5.0%
Not planned
4 Mar 2026
Potts Jeannette Chief Legal Officer
Sold at will
$30.91K 3,412 at 9.06
2.4%
Not planned
4 Mar 2026
Abi-Saab Walid Chief Medical Officer
Sold at will
$7.32K 808 at 9.06
0.4%
Not planned
2 Mar 2026
Kapusta Matthew C CEO, Managing Director
Sold at will
$342.65K 34,437 at 9.95
5.4%
Not planned
2 Mar 2026
KLEMT CHRISTIAN Chief Financial Officer
Sold at will
$124.69K 12,532 at 9.95
5.9%
Not planned
2 Mar 2026
Potts Jeannette Chief Legal Officer
Sold at will
$85.35K 8,578 at 9.95
7.5%
Not planned
2 Mar 2026
Abi-Saab Walid Chief Medical Officer
Sold at will
$16.52K 1,660 at 9.95
1.1%
Not planned
25 Feb 2026
Kapusta Matthew C CEO, Managing Director
Sold at will
$295.34K 12,378 at 23.86
1.9%
Not planned
25 Feb 2026
KLEMT CHRISTIAN Chief Financial Officer
Sold at will
$148.34K 6,217 at 23.86
2.9%
Not planned
12 Jan 2026
Gut Robert Director
Sold on a plan 3×
$630.48K 25,613 at 24.62
44.2%
Planned (10b5-1)
9 Jan 2026
Kaye Jack Director
Sold on a plan
$174.32K 6,390 at 27.28
23.8%
Planned (10b5-1)
6 Nov 2025
Gut Robert Director
Sold on a plan 2×
$856.88K 31,434 at 27.26
43.9%
Planned (10b5-1)
4 Nov 2025
Kaye Jack Director
Sold on a plan 3×
$1.18M 38,810 at 30.34
65.5%
Sold half or more
Showing 1–37 of 37.